Wordt geladen...
IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations
In the 2016, WHO classification of tumors of the central nervous system, isocitrate dehydrogenase (IDH) mutation is a main classifier for lower grade astrocytomas and IDH‐mutated astrocytomas is now regarded as a single group with longer survival. However, the molecular and clinical heterogeneity am...
Bewaard in:
| Gepubliceerd in: | Brain Pathol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018138/ https://ncbi.nlm.nih.gov/pubmed/31733156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12801 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|